Merck Tbk PT

Merck Tbk PT FCF Yield

The Free Cash Flow Yield of Merck Tbk PT (MERK.JK) as of Oct 18, 2026 is 25.17 %. In the previous year, Free Cash Flow Yield was 2.71 % — a change of 828.24% (higher).

FCF Yield

25.17 %

YoY

828.24%

Last updated:

Free Cash Flow Yield of Merck Tbk PT is 2025 25.17 % . Free Cash Flow Yield of Merck Tbk PT was 2024 2.71 % . It decreases by 828.24% higher compared to the previous year.

The Merck Tbk PT FCF Yield history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Yield
Date
FCF Yield
Jan 1, 2018
10.12 IDR
Jan 1, 2019
-16.79 IDR
Jan 1, 2020
2.83 IDR
Jan 1, 2021
8.84 IDR
Jan 1, 2022
6.29 IDR
Jan 1, 2023
12.83 IDR
Jan 1, 2024
2.71 IDR
Jan 1, 2025
25.17 IDR
The Merck Tbk PT FCF Yield history
YEARFCF YieldYoY
25.17 %+828.24%
2.71 %-78.87%
12.83 %+104.10%
6.29 %-28.87%
8.84 %+212.44%
2.83 %-116.85%
-16.79 %-265.91%
10.12 %+125.38%
4.49 %+251.60%
1.28 %-81.97%
7.08 %-51.51%
14.61 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

Free Cash Flow Yield of Merck Tbk PT is 25.17 % in 2025.

Free Cash Flow Yield of Merck Tbk PT changed from 2.71 % to 25.17 %, representing a 828.24% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Yield Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.

To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Merck Tbk PT with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Merck Tbk PT

All Key Metrics — Merck Tbk PT